Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company developing innovative vaccines, is advancing TNX-801, a live, minimally replicatin ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 19.78%, which has investors questioning if this is right ...

Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore ...

Key Laboratory of Green Chemical Media and Reactions, Ministry of Education; Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions; School of Chemistry ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

After hours: March 19 at 7:59:43 PM EDT Loading Chart for TNXP ...

Microscopy with gram stain (%) 91 (80 to 96) 96 (92 to 98) 55 0.4 Microscopy without gram stain (%) 88 (75 to 94) 92 (83 to 96) 37 0.7 Either leucocyte esterase or nitrite positive (%) 88 (82 to 91) ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced its fourth-quarter and full-year 2024 financial results, alongside key operational updates. The compan ...

More information: Sesh A. Sundararaman et al, Prodrug activation in malaria parasites mediated by an imported erythrocyte ...